Literature DB >> 3773991

Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

A P Monaco, R L Neve, C Colletti-Feener, C J Bertelson, D M Kurnit, L M Kunkel.   

Abstract

Duchenne muscular dystrophy (DMD) and the less severe Becker muscular dystrophy (BMD) are human X-linked muscle-wasting disorders that have been localized to the band Xp21 by genetic linkage analysis and cytologically detectable abnormalities. A cloned DNA segment, DXS164 (or pERT87), has been shown to detect deletions in the DNA of unrelated DMD and BMD males. Here we present the nucleotide sequence of two highly conserved DNA fragments from the DXS164 locus and their homologous sequences from the mouse X chromosome. One of the human conserved segments hybridized to a large transcript in RNA isolated from human fetal skeletal muscle and was used to isolate cDNA clones which cover approximately 10% of this transcript. The cDNA clones map to Xp21 and hybridize with a minimum of eight small regions that span 130 kilobases (kb) of the DXS164 locus. These expressed sequences are candidates for portions of the gene responsible for both DMD and BMD.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3773991     DOI: 10.1038/323646a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  287 in total

1.  Myogenic stem cell function is impaired in mice lacking the forkhead/winged helix protein MNF.

Authors:  D J Garry; A Meeson; J Elterman; Y Zhao; P Yang; R Bassel-Duby; R S Williams
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

2.  [Computer experience and further developments in the respiratory function laboratory (author's transl)].

Authors:  R Schindl; K Mayer; K Aigner
Journal:  Med Klin       Date:  1975-11-07

3.  Physiological characterization of muscle strength with variable levels of dystrophin restoration in mdx mice following local antisense therapy.

Authors:  Paul S Sharp; Hema Bye-a-Jee; Dominic J Wells
Journal:  Mol Ther       Date:  2010-10-05       Impact factor: 11.454

4.  Function induced modifications of gene expression: an alternative approach to gene therapy of Duchenne muscular dystrophy.

Authors:  Gerta Vrbová
Journal:  J Muscle Res Cell Motil       Date:  2004       Impact factor: 2.698

5.  Detection of multiallele polymorphisms within gene sequences by GC-clamped denaturing gradient gel electrophoresis.

Authors:  V C Sheffield; J S Beck; B Nichols; A Cousineau; A C Lidral; E M Stone
Journal:  Am J Hum Genet       Date:  1992-03       Impact factor: 11.025

6.  Physical analysis of murine albino deletions that disrupt liver-specific gene regulation or mesoderm development.

Authors:  M L Klebig; B S Kwon; E M Rinchik
Journal:  Mamm Genome       Date:  1992       Impact factor: 2.957

Review 7.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

8.  Signs of progress in gene therapy for muscular dystrophy also warrant caution.

Authors:  Hansell H Stedman; Barry J Byrne
Journal:  Mol Ther       Date:  2012-02       Impact factor: 11.454

9.  Characterization of patients with glycerol kinase deficiency utilizing cDNA probes for the Duchenne muscular dystrophy locus.

Authors:  J A Towbin; D R Wu; J Chamberlain; P D Larsen; W K Seltzer; E R McCabe
Journal:  Hum Genet       Date:  1989-09       Impact factor: 4.132

Review 10.  Diagnosis and cell-based therapy for Duchenne muscular dystrophy in humans, mice, and zebrafish.

Authors:  Louis M Kunkel; Estanislao Bachrach; Richard R Bennett; Jeffrey Guyon; Leta Steffen
Journal:  J Hum Genet       Date:  2006-04-01       Impact factor: 3.172

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.